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Reply to the Editor:
We thank Drs Evora and Rodrigues for their
interest in our case report and their com-
ments. The clinical improvement as de-
scribed in the series by Leyh and associates1
and the case reports by Grayling,2 Sparicio,3
and their colleagues, was not evident in our
case. Those authors described dramatic im-
provements in mean arterial pressure with
commencement of methylene blue (MB); our
patient experienced no such benefit. Norepi-
nephrine, epinephrine, and vasopressin re-
quirements persisted for at least the first 24
hours after the operation in our case. Her
treating intensivists believe that her postop-
erative course was not significantly shortened
by the use of MB. The dose used (2 mg/kg at
induction of anaesthesia, 2 mg/kg on initia-
tion of CPB, and an infusion of 1 mg/kg per
hour for a total of 4 hours) was based on the
description by Grayling and Deakin,2 which
is longer than that used by others.1,3
Nitric oxide vasodilation is implicated
in both sepsis and the refractory vasoplegia
associated with cardiopulmonary bypass
(CPB). The different outcomes in the stud-
ies of MB in the septic group and our
patient may be due to the different pathol-
ogy and underlying heterogeneity of septic
patients.4 A case report of dramatic im-
provement after MB in a patient with in-
fective endocarditis refutes this.2Evora and
Rodrigues describe the “random” efficacy
of MB when used as a “last minute vaso-
pressor.” The evidence for use of MB as
anything other than the “last minute vaso-
pressor” in such situations does not exist
for children. We, therefore, reiterate the
need for clinical trials to answer this ques-
tion.
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Assumed oxygen consumption in the
determination of cardiac output in
children after cardiac surgery
To the Editor:
We read with interest the article by Fakler
and associates1 titled “Assumed oxygen
consumption frequently results in large er-
rors in the determination of cardiac out-
put.” However, we were surprised that our
previous article was not cited. We used
respiratory mass spectrometry to continu-
ously measure oxygen consumption (VO2)
and compared these direct measurements
with estimated VO2 values using 4 equa-
tions, including that of Lafarge and Miet-
tinen. We studied ventilated children with
congenital heart disease both during car-
diac catheterization and in the intensive
care unit early after cardiopulmonary by-
pass surgery.2 We showed an overestima-
tion of VO2 in children during cardiac cath-
eterization and an underestimation in the
postoperative children, with all 4 equations
being particularly unreliable in the postop-
erative group.
As rightly pointed out by Fakler and
colleagues,1 use of assumed VO2 will result
in large errors in the calculation of hemo-
dynamic variables, such as cardiac output
and systemic and pulmonary vascular re-
sistance. This issue becomes particularly
important in patients during the early post-
operative period, when VO2 is not only
increased as a result of systemic inflamma-
tory response syndrome but is also highly
dependent on temperature,3 the use of ino-
tropes and vasoactive drugs,4 and ventila-
tory manipulation.5 Thus although the con-
clusions of Fakler and colleagues1 support
our previous observations regarding the use
of estimated VO2 during cardiac catheter-
ization, we believe our data suggest the
need for even greater caution in the more
highly dynamic hemodynamic milieu of
the postoperative cardiac intensive care
unit.
Jia Li, MD, PhD
Igor E. Konstantinov, MD, PhD
Glen S. Van Arsdell, MD
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